Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the woocommerce-services domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /www/benchmarkantibodiescom_769/public/wp-includes/functions.php on line 6121

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the woocommerce-payments domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /www/benchmarkantibodiescom_769/public/wp-includes/functions.php on line 6121
PD-L1 – benchmark antibodies PD-L1
Skip to content
Close

Showing the single result

PD-L1

PD-L1: PD-L1 is an immune checkpoint protein expressed in various tumors. Its detection aids in identifying candidates for immune checkpoint blockade therapies, providing critical insights into treatment options.



target type reactivity applications
6328 PD-L1 rabbit monoclonal (ZR3) human IHC

Human lung adenocarcinoma stained with anti-PD-L1 (Clone ZR3) using peroxidase-conjugate and DAB chromogen. Note membranous staining of tumor cells.
IHC with antibody [6328] : Human lung adenocarcinoma stained with anti-PD-L1 (Clone ZR3) using peroxidase-conjugate and DAB chromogen. Note membranous staining of tumor cells.
ICC
IHC